Viral hepatitis includes both hepatitis B and hepatitis C. The Ohio State University Wexner Medical Center’s Na Li, MD, PhD, explains that there have been promising medical advancements to cure hepatitis C, while hepatitis B presents more challenges.

As a chronic condition, medications are used to manage hepatitis B, depending on the particular phase of infection, as well as other existing medical conditions or infections such as hepatitis C or HIV. Dr. Li emphasizes the need for monitoring patients with past or current hepatitis B infections, because there is greater risk of cancer. In addition, chemotherapy may reactivate hepatitis B.

To learn more or to schedule an appointment, visit https://internalmedicine.osu.edu/digestivediseases/
or call (614) 293-6255.

Visit The Ohio State University Wexner Medical Center: https://wexnermedical.osu.edu/

Subscribe to The Ohio State University Wexner Medical Center YouTube channel: https://www.youtube.com/user/osumedicalcenter

Like The Ohio State University Wexner Medical Center on Facebook: http://www.facebook.com/OSUWexnerMedicalCenter/

Follow The Ohio State University Wexner Medical Center on Twitter: http://www.twitter.com/osuwexmed

Follow The Ohio State University Wexner Medical Center on Instagram: http://www.instagram.com/osuwexmed

Connect with The Ohio State University Wexner Medical Center on LinkedIn: https://www.linkedin.com/company/the-ohio-state-university-wexner-medical-center

Hepatitis B Cure

Lectured by
Sharon Lewin, FRACP, PhD, FAAHMS
Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia

in 22nd Bangkok International Symposium on HIV Medicine 2020
on January 15-17, 2020 at BITEC, Bangkok, Thailand
http://www.hivnat.org/bangkoksymposium